The Technical Analyst
Sientra Inc [SIEN]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Sientra Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-18.69% $0.174
America/New_York / 21 feb 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2.08 mill |
| EPS: | -5.26 |
| P/E: | -0.0331 |
| Earnings Date: | Mar 27, 2024 |
| SharesOutstanding: | 11.96 mill |
| Avg Daily Volume: | 2.47 mill |
| RATING 2024-02-21 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0331 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.0331 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ -0.0410 - 0.185 ( +/- 156.94%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-11-13 | Menezes Ronald | Sell | 3 625 | Common Stock |
| 2023-11-13 | Van Hove Caroline F. | Sell | 741 | Common Stock |
| 2023-09-07 | Bennett Oliver Christian | Buy | 2 739 | Common Stock |
| 2023-08-03 | Schmidt Andrew C | Sell | 561 | Common Stock |
| 2023-06-15 | Schaison Philippe | Buy | 12 000 | Common Stock |
| INSIDER POWER |
|---|
| 63.06 |
| Last 97 transactions |
| Buy: 2 046 240 | Sell: 1 259 742 |
Forecast:
01:40 - $0.0970
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.174 (-18.69% ) |
| Volume | 3.33 mill |
| Avg. Vol. | 2.47 mill |
| % of Avg. Vol | 134.88 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SIEN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Last 10 Buy Signals
Latest Press Releases
2024-04-02 18:30:00 - Press Release
Sientra Announces Completion And Winning Bidders Of Its Section 363 Sales Auction
Tiger aesthetics medical, llc is the successful bidder for certain assets used in sientra's breast reconstruction and augmentation business
2024-02-13 08:30:00 - Press Release
Sientra To Pursue Strategic Sale Of Its Business Through Voluntary Chapter 11 Process
Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale process company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale process
2023-11-09 16:05:00 - Press Release
Sientra Reports Third Quarter Financial And Operational Results
Irvine, calif., nov. 09, 2023 (globe newswire) -- sientra, inc. (nasdaq: sien) (“sientra” or the “company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its financial results for the third quarter that ended september 30, 2023.
2023-11-08 08:35:00 - Press Release
Sientra To Present At The Stifel 2023 Healthcare Conference
Irvine, calif., nov. 08, 2023 (globe newswire) -- sientra, inc. (nasdaq: sien) (“sientra” or the “company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its participation at the stifel 2023 healthcare conference. as part of the conference, the company's management team will participate in a live fireside chat on wednesday, november 15, 2023 at 8:00am est / 5:00am pst.
2023-10-30 17:00:00 - Press Release
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results And Provides Update On Outlook
Irvine, calif., oct. 30, 2023 (globe newswire) -- sientra, inc. (nasdaq: sien) (“sientra” or the “company”), a surgical aesthetics company delivering the safest and most innovative solutions for the best outcomes, today announced preliminary unaudited financial results for the fiscal third quarter ended september 30, 2023.
Latest News
2023-11-09 22:39:04 - Seeking Alpha
Sientra, Inc. (SIEN) Q3 2023 Earnings Call Transcript
Sientra, Inc. (NASDAQ:SIEN ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Oliver Bennett - Chief Legal, Compliance and Corporate Development Officer Ron Menezes - President and Chief Executive Officer Denise Dajles - Chief Technical Officer Andy Schmidt - Chief Financial Officer Conference Call Participants Jordan Bernstein - Stifel Jeremy Pearlman - Maxim Group Operator Good afternoon and welcome to the Sientra Third Quarter 2023 Financial Results Conference Call. My name is Dave.
2023-11-08 08:35:00 - GlobeNewsWire
Sientra to Present at the Stifel 2023 Healthcare Conference
IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its participation at the Stifel 2023 Healthcare Conference. As part of the conference, the company's management team will participate in a live fireside chat on Wednesday, November 15, 2023 at 8:00am EST / 5:00am PST.
2023-09-21 16:43:09 - InvestorPlace
The 7 Best Short-Squeeze Stocks to Buy Now: September 2023
The best short-squeeze stocks to buy now can be a perilous territory in the investment landscape. However, they also possess the potential for astronomical returns.
2023-08-10 19:01:29 - Zacks Investment Research
Sientra (SIEN) Reports Q2 Loss, Lags Revenue Estimates
Sientra (SIEN) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $0.88. This compares to loss of $2.90 per share a year ago.
2023-07-27 04:05:00 - GlobeNewsWire
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced that it will release financial results for the second quarter of 2023 after the close of trading on Thursday, August 10, 2023. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.
2023-06-15 22:25:24 - 24/7 Wall Street
As Sientra Options Become Less Bullish This Week, Short Sellers Are Moving In
After Sientra ( US:SIEN ) announced last week that the FDA had approved the company's tissue expander, the shares' put/call ratio remains very favorable this week, and the number of purchases of SIEN stock options held by investors surged on June 12, data from Fintel shows.
2023-06-09 08:30:00 - Market Watch
Sientra stock rockets to pace premarket gainers after FDA clearance of tissue expander
Shares of Sientra Inc. SIEN, +3.55% skyrocketed 82.3% toward a seven-month high on heavy volume to pace all premarket gainers Friday after the medical aesthetics company after the U.S. Food and Drug Administration granted 510(k)-clearance for its AlloX2 Pro Tissue Expander. Trading volume ballooned to 4.2 million shares, compared with the full-day average of about 328,900 shares.
2023-06-05 09:55:09 - Zacks Investment Research
Why Fast-paced Mover Sientra (SIEN) Is a Great Choice for Value Investors
Sientra (SIEN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
2023-05-18 09:58:13 - Zacks Investment Research
Despite Fast-paced Momentum, Sientra (SIEN) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sientra (SIEN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
2023-05-11 19:55:23 - Seeking Alpha
Sientra, Inc. (SIEN) Q1 2023 Earnings Call Transcript
Sientra, Inc. (NASDAQ:SIEN ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Oliver Bennett - Chief Legal Compliance and CDO Ron Menezes - President and CEO Andy Schmidt - Chief Financial Officer Denise Dajles - Chief Technical Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Joe Federico - Stifel Anthony Vendetti - Maxim Group Operator Good afternoon, everybody. And welcome to Sientra's First Quarter 2023 Financial Results Conference Call.